Key characteristics of 86 agents known to cause cancer in humans

ABSTRACT Since the inception of the International Agency for Research on Cancer (IARC) in the early 1970s, the IARC Monographs Programme has evaluated more than 1000 agents with respect to carcinogenic hazard; of these, up to and including Volume 119 of the IARC Monographs, 120 agents met the criteria for classification as carcinogenic to humans (Group 1). Volume 100 of the IARC Monographs provided a review and update of Group 1 carcinogens. These agents were divided into six broad categories: (I) pharmaceuticals; (II) biological agents; (III) arsenic, metals, fibers, and dusts; (IV) radiation; (V) personal habits and indoor combustions; and (VI) chemical agents and related occupations. Data on biological mechanisms of action (MOA) were extracted from the Monographs to assemble a database on the basis of ten key characteristics attributed to human carcinogens. After some grouping of similar agents, the characteristic profiles were examined for 86 Group 1 agents for which mechanistic information was available in the IARC Monographs up to and including Volume 106, based upon data derived from human in vivo, human in vitro, animal in vivo, and animal in vitro studies. The most prevalent key characteristic was “is genotoxic”, followed by “alters cell proliferation, cell death, or nutrient supply” and “induces oxidative stress”. Most agents exhibited several of the ten key characteristics, with an average of four characteristics per agent, a finding consistent with the notion that cancer development in humans involves multiple pathways. Information on the key characteristics was often available from multiple sources, with many agents demonstrating concordance between human and animal sources, particularly with respect to genotoxicity. Although a detailed comparison of the characteristics of different types of agents was not attempted here, the overall characteristic profiles for pharmaceutical agents and for chemical agents and related occupations appeared similar. Further in-depth analyses of this rich database of characteristics of human carcinogens are expected to provide additional insights into the MOA of human cancer development.

[1]  U. Epa.  Guidelines for carcinogen risk assessment , 1986 .

[2]  H. Vainio.  Mechanisms of Carcinogenesis in Risk Identification , 1992 .

[3]  C. Wild,et al.  Fifty years of the International Agency for Research on Cancer (1965 to 2015) , 2016, International journal of cancer.

[4]  Marta Cascante,et al.  Targeting cell cycle regulation in cancer therapy. , 2013, Pharmacology & therapeutics.

[5]  Shaoyu Zhou,et al.  Oxidative stress and oxidative damage in chemical carcinogenesis. , 2011, Toxicology and applied pharmacology.

[6]  F. Kronenberg,et al.  Telomere length and risk of incident cancer and cancer mortality. , 2010, JAMA.

[7]  Kurt Straif,et al.  Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. , 2014, The Lancet. Oncology.

[8]  Robert A. Baan,et al.  The Science and Practice of Carcinogen Identification and Evaluation , 2004, Environmental health perspectives.

[9]  Ronald D Snyder,et al.  Possible structural and functional determinants contributing to the clastogenicity of pharmaceuticals , 2010, Environmental and molecular mutagenesis.

[10]  Ivan Rusyn,et al.  Application of the key characteristics of carcinogens in cancer hazard identification , 2018, Carcinogenesis.

[11]  I. O'neill,et al.  Preamble to the IARC Monographs , 2009 .

[12]  humAn cArcinogens,et al.  [Biological agents]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[13]  Ivan Rusyn,et al.  Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis , 2015, Environmental health perspectives.

[14]  Ivan Rusyn,et al.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. , 2016, Mutation research. Reviews in mutation research.

[15]  Division on Earth.  Review of Epa's Integrated Risk Information System (Iris) Process , 2014 .

[16]  D. Krewski,et al.  A Framework for the Next Generation of Risk Science , 2014, Environmental health perspectives.

[17]  Iarc Monographs,et al.  TRICHLOROETHYLENE, TETRACHLOROETHYLENE, AND SOME OTHER CHLORINATED AGENTS. , 2014, IARC monographs on the evaluation of carcinogenic risks to humans.

[18]  Kyriacos Patatas.  Radiation , 2008, BMJ : British Medical Journal.

[19]  V. Weaver,et al.  The extracellular matrix modulates the hallmarks of cancer , 2014, EMBO reports.

[20]  C. Walker.  Polychlorinated biphenyls and polybrominated biphenyls , 2001 .

[21]  W. Teague,et al.  Outdoor air pollution. Asthma and other concerns. , 2001, Pediatric clinics of North America.

[22]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[23]  S. Baker.  A cancer theory kerfuffle can lead to new lines of research. , 2014, Journal of the National Cancer Institute.

[24]  Alessandro Spina.  Pharmaceuticals , 2010, European Journal of Risk Regulation.

[25]  Daniel Krewski,et al.  Technical guide for applications of gene expression profiling in human health risk assessment of environmental chemicals. , 2015, Regulatory toxicology and pharmacology : RTP.

[26]  Chemical agents and related occupations. , 2012, IARC monographs on the evaluation of carcinogenic risks to humans.

[27]  K. Straif,et al.  Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone. , 2014, The Lancet. Oncology.

[28]  H. van Steeg,et al.  Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach. , 2009, Mutation research.

[29]  Kurt Straif,et al.  Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid. , 2015, The Lancet. Oncology.

[30]  Mechanistic relationships between hepatic genotoxicity and carcinogenicity in male B6C3F1 mice treated with polycyclic aromatic hydrocarbon mixtures , 2015, Archives of Toxicology.

[31]  H. Bartsch,et al.  Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. , 1998, Mutation research.

[32]  J. Little,et al.  Analysis of tumour site concordance , 2019 .

[33]  humAn cArcinogens,et al.  iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns , 2012 .

[34]  Melvin E. Andersen,et al.  The Future of Toxicity Testing , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[35]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[36]  J. Hoeijmakers.  DNA damage, aging, and cancer. , 2009, The New England journal of medicine.

[37]  R. Reddel.  The role of senescence and immortalization in carcinogenesis. , 2000, Carcinogenesis.

[38]  J A Miller,et al.  Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.

[39]  M. Valley,et al.  Outdoor Air Pollution. , 2016, IARC monographs on the evaluation of carcinogenic risks to humans.

[40]  Paul A. Schulte,et al.  The Next Generation of Risk Assessment Multi-Year Study—Highlights of Findings, Applications to Risk Assessment, and Future Directions , 2016, Environmental health perspectives.

[41]  M E Meek,et al.  New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis , 2013, Journal of applied toxicology : JAT.

[42]  Kurt Straif,et al.  Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes. , 2012, The Lancet. Oncology.

[43]  N. Birkett,et al.  Analysis of key characteristics of human carcinogens , 2019 .

[44]  Report on carcinogens. , 2004, Report on carcinogens : carcinogen profiles.

[45]  Kurt Straif,et al.  Carcinogenicity of consumption of red and processed meat. , 2015, The Lancet. Oncology.

[46]  J. Bailar,et al.  Toxicity Testing in the 21st Century: A Vision and a Strategy , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[47]  D. Krewski,et al.  The role of human biological monitoring in health risk assessment , 2017 .

[48]  D. Krewski,et al.  Overview of biological mechanisms of human carcinogens , 2019, Journal of toxicology and environmental health. Part B, Critical reviews.

[49]  Polybrominated Biphenyls.  Polychlorinated Biphenyls and Polybrominated Biphenyls. , 2016, IARC monographs on the evaluation of carcinogenic risks to humans.

[50]  K. Munger,et al.  Human viral oncogenesis: a cancer hallmarks analysis. , 2014, Cell host & microbe.

[51]  Kurt Straif,et al.  The carcinogenicity of outdoor air pollution. , 2013, The Lancet Oncology.

[52]  Carine Maenhaut,et al.  Hallmarks of cancer: of all cancer cells, all the time? , 2012, Trends in molecular medicine.

[53]  K. Straif,et al.  Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. , 2013, The Lancet. Oncology.

[54]  Paolo Vineis,et al.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. , 2013, Carcinogenesis.

[55]  Arsenic, metals, fibres, and dusts. , 2012, IARC monographs on the evaluation of carcinogenic risks to humans.

[56]  H. Bartsch,et al.  Prevalence of genotoxic chemicals among animal and human carcinogens evaluated in the IARC Monograph series. , 1989, Cell Biology and Toxicology.

[57]  Gabriele Multhoff,et al.  Radiation, Inflammation, and Immune Responses in Cancer , 2012, Front. Oncol..

[58]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[59]  Benedetto Terracini,et al.  International Agency for Research on Cancer. The first 50 years , 2016 .

[60]  M. Dewhirst,et al.  Linking the History of Radiation Biology to the Hallmarks of Cancer , 2014, Radiation research.

[61]  K. Straif,et al.  Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites. , 2012, The Lancet. Oncology.